← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Metcure Therapeutics, Llc
Atlanta, GA
$2,546,169
Total funding
4
Grants
Funding over time
peak $1M · FY2015–22$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$2,546,169 · 4
By mechanism
R42$1,935,175 · 1
R41$610,994 · 3
Investigators at Metcure Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
Small-molecule therapy for metastatic castration-resistant prostate cancer$1,007,817
R42 · FY2021 · CA
Small-molecule therapy for metastatic castration-resistant prostate cancer$927,358
R42 · FY2022 · CA
Novel small-molecule targeted therapy for prostate cancer$224,999
R41 · FY2016 · CA
Small-molecule therapy for metastatic prostate cancer$224,999
R41 · FY2017 · CA
A Dietary Supplement As Adjunct Therapy In Castration-Resistant Prostate Cancer$160,996
R41 · FY2015 · CA